seeing as we are now seeing many indications that our stuff works wonders for inflammation. I wonder as have a few others what's happening with this application? the last p2 was in 2015 some 3 years back now.
all results point towards us being very good at anti inflammatory responses which is valuable. I can only assume MSB management has for now decided they cannot afford the cost to progress this. or a partner is not forthcoming to chip in for it.
MPC-300-IV
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |